Pembrolizumab: first adjuvant immunotherapy in renal cell carcinoma?

Saved in:
Bibliographic Details
Published in:Future oncology (London, England) England), 2022-02, Vol.18 (5), p.519-522
Main Authors: Saleh, Khalil, Kordahi, Manal, Felefly, Tony, Kourie, Hampig Raphael, Khalife, Nadine
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal, Humanized - therapeutic use
Carcinoma, Renal Cell - drug therapy
Chemotherapy, Adjuvant
Clinical Trials as Topic
Humans
Immune Checkpoint Inhibitors - therapeutic use
immunotherapy
Immunotherapy - methods
ipilimumab
Kidney Neoplasms - drug therapy
Nephrectomy
nivolumab
pembrolizumab
renal cell carcinoma
tyrosine kinase inhibitor
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1479-6694
1744-8301
DOI:10.2217/fon-2021-1309